Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rongce Zhao

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Oncotarget|October 6, 2017
Antitumor immunity induced by VE-cadherin modified DC vaccineJing Zhou, Yufeng Xi, Xiyan Mu, et al.
Frontiers in Pharmacology|June 8, 2023
A novel benzothiazole derivative induces apoptosis via the mitochondrial intrinsic pathway producing antitumor activity in colorectal cancerJing Zhou, Rongce Zhao, Haoxuan Zhou, et al.
Gene|August 3, 2017
Hypomethylation of BORIS is a promising prognostic biomarker in hepatocellular carcinomaJingyang He, Yuan Huang, Zhongjian Liu, et al.
Journal of Gastroenterology and Hepatology|December 22, 2018
Antitumor activity in colorectal cancer induced by hinokiflavoneJing Zhou, Rongce Zhao, Tinghong Ye, et al.
Medical Oncology (Northwood, London, England)|March 20, 2015
Cost-effectiveness analysis of gemcitabine, S-1 and gemcitabine plus S-1 for treatment of advanced pancreatic cancer based on GEST studyJing Zhou, Rongce Zhao, Feng Wen, et al.
Tumori|April 9, 2016
Cost-effectiveness analysis of treatments for metastatic pancreatic cancer based on PRODIGE and MPACT trialsJing Zhou, Rongce Zhao, Feng Wen, et al.
Annals of Medicine|March 11, 2022
Real-world outcomes of patients with advanced intrahepatic cholangiocarcinoma treated with programmed cell death protein-1-targeted immunotherapyMin Deng, Shaohua Li, Qiaoxuan Wang, et al.
Frontiers in Immunology|November 7, 2024
Comparing PD-L1 with PD-1 antibodies combined with lenvatinib and hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinomaShaohua Li, Jie Mei, Rongce Zhao, et al.
Cell Biology International|June 3, 2015
Disruption of human vigilin impairs chromosome condensation and segregationLing Wei, Xiaoyan Xie, Junhong Li, et al.
Frontiers in Immunology|January 27, 2025
Prognosis prediction of α-FAtE score for locoregional immunotherapy in hepatocellular carcinomaZehao Zheng, Renguo Guan, Rongce Zhao, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Oncotarget|October 6, 2017
Antitumor immunity induced by VE-cadherin modified DC vaccineJing Zhou, Yufeng Xi, Xiyan Mu, et al.
Frontiers in Pharmacology|June 8, 2023
A novel benzothiazole derivative induces apoptosis via the mitochondrial intrinsic pathway producing antitumor activity in colorectal cancerJing Zhou, Rongce Zhao, Haoxuan Zhou, et al.
Gene|August 3, 2017
Hypomethylation of BORIS is a promising prognostic biomarker in hepatocellular carcinomaJingyang He, Yuan Huang, Zhongjian Liu, et al.
Journal of Gastroenterology and Hepatology|December 22, 2018
Antitumor activity in colorectal cancer induced by hinokiflavoneJing Zhou, Rongce Zhao, Tinghong Ye, et al.
Medical Oncology (Northwood, London, England)|March 20, 2015
Cost-effectiveness analysis of gemcitabine, S-1 and gemcitabine plus S-1 for treatment of advanced pancreatic cancer based on GEST studyJing Zhou, Rongce Zhao, Feng Wen, et al.
Tumori|April 9, 2016
Cost-effectiveness analysis of treatments for metastatic pancreatic cancer based on PRODIGE and MPACT trialsJing Zhou, Rongce Zhao, Feng Wen, et al.
Annals of Medicine|March 11, 2022
Real-world outcomes of patients with advanced intrahepatic cholangiocarcinoma treated with programmed cell death protein-1-targeted immunotherapyMin Deng, Shaohua Li, Qiaoxuan Wang, et al.
Frontiers in Immunology|November 7, 2024
Comparing PD-L1 with PD-1 antibodies combined with lenvatinib and hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinomaShaohua Li, Jie Mei, Rongce Zhao, et al.
Cell Biology International|June 3, 2015
Disruption of human vigilin impairs chromosome condensation and segregationLing Wei, Xiaoyan Xie, Junhong Li, et al.
Frontiers in Immunology|January 27, 2025
Prognosis prediction of α-FAtE score for locoregional immunotherapy in hepatocellular carcinomaZehao Zheng, Renguo Guan, Rongce Zhao, et al.
Pageof 3